{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:47:11Z","timestamp":1791863231113,"version":"4.3.4"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"the Midlands Integrative Biosciences Training Partnership (MIBTP)"},{"DOI":"10.13039\/501100000268","name":"the Biotechnology and Biological Sciences Research Council (BBSRC)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"the Medical Research Council (MRC)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006500","name":"the CHDI Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006500","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cell & Developmental Biology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.semcdb.2015.03.002","type":"journal-article","created":{"date-parts":[[2015,3,12]],"date-time":"2015-03-12T08:01:52Z","timestamp":1426147312000},"page":"134-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":282,"special_numbering":"C","title":["The kynurenine pathway and neurodegenerative disease"],"prefix":"10.1016","volume":"40","author":[{"given":"Daniel C.","family":"Maddison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flaviano","family":"Giorgini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcdb.2015.03.002_bib0470","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0006-8993(85)90647-X","article-title":"Quinolinic acid phosphoribosyltransferase in human and rat brain: activity in Huntington's disease and in quinolinate-lesioned rat striatum","volume":"336","author":"Foster","year":"1985","journal-title":"Brain Res"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0475","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1742-4658.2007.05635.x","article-title":"Tissue expression and biochemical characterization of human 2-amino 3-carboxymuconate 6-semialdehyde decarboxylase, a key enzyme in tryptophan catabolism","volume":"274","author":"Pucci","year":"2007","journal-title":"FEBS J"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0480","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-2999(81)90587-2","article-title":"Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS","volume":"72","author":"Stone","year":"1981","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0485","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF01262727","article-title":"Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice","volume":"42","author":"Lapin","year":"1978","journal-title":"J Neural Transm"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0490","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.6849138","article-title":"Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain","volume":"219","author":"Schwarcz","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0495","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0028-3908(83)90221-6","article-title":"On the excitotoxic properties of quinolinic acid, 2,3-piperidine dicarboxylic acids and structurally related compounds","volume":"22","author":"Foster","year":"1983","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0500","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0304-3940(89)90609-5","article-title":"Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system","volume":"97","author":"Whetsell","year":"1989","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0505","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0197-0186(01)00133-4","article-title":"Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes","volume":"40","author":"Tavares","year":"2002","journal-title":"Neurochem Int"},{"issue":"36","key":"10.1016\/j.semcdb.2015.03.002_bib0510","article-title":"Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease","volume":"6","author":"Ting","year":"2009","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0515","first-page":"1","article-title":"Quinolinic acid, an endogenous molecule combining excitotoxicity, oxidative stress and other toxic mechanisms","volume":"5","author":"Perez-De La Cruz","year":"2012","journal-title":"Int J Tryptophan Res"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0520","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/BF00966592","article-title":"Quinolinic acid is a potent lipid peroxidant in rat brain homogenates","volume":"16","author":"Rios","year":"1991","journal-title":"Neurochem Res"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0525","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0304-3940(93)90796-N","article-title":"MK-801 an N-methyl-d-aspartate receptor antagonist, blocks quinolinic acid-induced lipid peroxidation in rat corpus striatum","volume":"159","author":"Santamaria","year":"1993","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0530","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0197-0186(97)90002-4","article-title":"The effect of quinolinate on rat brain lipid peroxidation is dependent on iron","volume":"30","author":"Stipek","year":"1997","journal-title":"Neurochem Int"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0535","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/10715760100300391","article-title":"Quinolinic acid\u2013iron(ii) complexes: slow autoxidation, but enhanced hydroxyl radical production in the Fenton reaction","volume":"34","author":"Platenik","year":"2001","journal-title":"Free Radic Res"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0540","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12640-009-9051-z","article-title":"Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons","volume":"16","author":"Braidy","year":"2009","journal-title":"Neurotox Res"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0545","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1023\/A:1020700401678","article-title":"Nitric oxide synthase inhibition prevents acute quinolinate-induced striatal neurotoxicity","volume":"23","author":"Perez-Severiano","year":"1998","journal-title":"Neurochem Res"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0550","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/sj.bjp.0702940","article-title":"Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl","volume":"128","author":"Behan","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0555","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0306-4522(96)00034-6","article-title":"Antioxidant treatment protects striatal neurons against excitotoxic insults","volume":"73","author":"Nakao","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0560","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/10715760000300021","article-title":"Characterisation of the major autoxidation products of 3-hydroxykynurenine under physiological conditions","volume":"32","author":"Vazquez","year":"2000","journal-title":"Free Radic Res"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0565","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0006-291X(02)02917-0","article-title":"Electrochemical and in vitro evaluation of the redox-properties of kynurenine species","volume":"300","author":"Giles","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0570","doi-asserted-by":"crossref","first-page":"12553","DOI":"10.1073\/pnas.93.22.12553","article-title":"Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine","volume":"93","author":"Okuda","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0575","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1471-4159.1998.70010299.x","article-title":"3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity","volume":"70","author":"Okuda","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0580","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s12640-009-9034-0","article-title":"5-Hydroxyanthranilic acid, a tryptophan metabolite, generates oxidative stress and neuronal death via p38 activation in cultured cerebellar granule neurones","volume":"15","author":"Smith","year":"2009","journal-title":"Neurotox Res"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0585","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1046\/j.1460-9568.1999.00806.x","article-title":"3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum","volume":"11","author":"Guidetti","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0590","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.1021\/bi992997s","article-title":"3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction","volume":"39","author":"Goldstein","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0595","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1042\/bj2510893","article-title":"Superoxide dismutase enhances the formation of hydroxyl radicals in the reaction of 3-hydroxyanthranilic acid with molecular oxygen","volume":"251","author":"Iwahashi","year":"1988","journal-title":"Biochem J"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0600","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1073\/pnas.87.7.2506","article-title":"Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases","volume":"87","author":"Christen","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0605","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuint.2006.04.017","article-title":"In vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in the brain","volume":"50","author":"Leipnitz","year":"2007","journal-title":"Neurochem Int"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.09.034","article-title":"The Janus faces of 3-hydroxykynurenine: dual redox modulatory activity and lack of neurotoxicity in the rat striatum","volume":"1589","author":"Colin-Gonzalez","year":"2014","journal-title":"Brain Res"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0615","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ntt.2011.07.002","article-title":"On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress","volume":"33","author":"Lugo-Huitron","year":"2011","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0620","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","article-title":"The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications","volume":"21","author":"Hilmas","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0625","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0006-8993(82)91048-4","article-title":"An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid","volume":"247","author":"Perkins","year":"1982","journal-title":"Brain Res"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0630","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1042\/BST0370408","article-title":"Oxidation of l-tryptophan in biology: a comparison between tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase","volume":"37","author":"Rafice","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0635","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1002\/prot.24653","article-title":"Structural and functional analyses of human tryptophan 2,3-dioxygenase","volume":"82","author":"Meng","year":"2014","journal-title":"Proteins"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0640","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/abbi.2000.1755","article-title":"Heme: a regulator of rat hepatic tryptophan 2,3-dioxygenase?","volume":"377","author":"Ren","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0645","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/arch.20159","article-title":"Biochemical mechanisms leading to tryptophan 2,3-dioxygenase activation","volume":"64","author":"Li","year":"2007","journal-title":"Arch Insect Biochem Physiol"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0650","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/npp.2013.71","article-title":"NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL\/6J mice","volume":"38","author":"Walker","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0655","doi-asserted-by":"crossref","first-page":"19140","DOI":"10.1074\/jbc.271.32.19140","article-title":"Importance of the two interferon-stimulated response element (ISRE) sequences in the regulation of the human indoleamine 2,3-dioxygenase gene","volume":"271","author":"Konan","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0660","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fnins.2014.00012","article-title":"Kynurenines in CNS disease: regulation by inflammatory cytokines","volume":"8","author":"Campbell","year":"2014","journal-title":"Front Neurosci"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0665","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0021-9258(19)77982-4","article-title":"Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity","volume":"263","author":"Takikawa","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0670","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/npp.2011.277","article-title":"Interleukin-1beta: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis","volume":"37","author":"Zunszain","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0675","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neulet.2008.06.007","article-title":"Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma?","volume":"441","author":"Connor","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0680","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.euroneuro.2013.03.008","article-title":"Modulation of the inflammatory response in rats chronically treated with the antidepressant agomelatine","volume":"23","author":"Molteni","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0685","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1074\/jbc.M708192200","article-title":"Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment","volume":"283","author":"Giorgini","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0690","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4615-0135-0_12","article-title":"Expression of the kynurenine pathway enzymes in human microglia and macrophages","volume":"527","author":"Guillemin","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0695","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0891-5849(99)00272-5","article-title":"Comparative effects of oxygen on indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase of the kynurenine pathway","volume":"28","author":"Dang","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0700","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00964611","article-title":"l-Kynurenine: its synthesis and possible regulatory function in brain","volume":"5","author":"Gal","year":"1980","journal-title":"Neurochem Res"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0705","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1471-4159.1990.tb13296.x","article-title":"Uptake of kynurenine into rat brain slices","volume":"54","author":"Speciale","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0710","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","article-title":"Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection","volume":"78","author":"Guillemin","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0715","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1046\/j.1471-4159.1997.69010290.x","article-title":"Brain-specific modulation of kynurenic acid synthesis in the rat","volume":"69","author":"Gramsbergen","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0720","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0006-8993(98)00577-0","article-title":"Systemic d-amphetamine administration causes a reduction of kynurenic acid levels in rat brain","volume":"802","author":"Rassoulpour","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0725","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1471-4159.1993.tb05840.x","article-title":"On the production and disposition of quinolinic acid in rat brain and liver slices","volume":"60","author":"Speciale","year":"1993","journal-title":"J Neurochem"},{"issue":"Pt 6","key":"10.1016\/j.semcdb.2015.03.002_bib0730","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/brain\/116.6.1425","article-title":"A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from l-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate","volume":"116","author":"Heyes","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0735","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1471-4159.1986.tb02826.x","article-title":"Synthesis of quinolinic acid by 3-hydroxyanthranilic acid oxygenase in rat brain tissue in vitro","volume":"47","author":"Foster","year":"1986","journal-title":"J Neurochem"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0740","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","article-title":"Blood\u2013brain barrier transport of kynurenines: implications for brain synthesis and metabolism","volume":"56","author":"Fukui","year":"1991","journal-title":"J Neurochem"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0745","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0750","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1073\/pnas.0308679101","article-title":"Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset","volume":"101","author":"Wexler","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0755","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nbd.2004.07.006","article-title":"Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease","volume":"17","author":"Guidetti","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0760","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-510X(94)00280-2","article-title":"Dysfunction of brain kynurenic acid metabolism in Huntington's disease: focus on kynurenine aminotransferases","volume":"130","author":"Jauch","year":"1995","journal-title":"J Neurol Sci"},{"issue":"Pt 5","key":"10.1016\/j.semcdb.2015.03.002_bib0765","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/brain\/115.5.1249","article-title":"Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease","volume":"115","author":"Heyes","year":"1992","journal-title":"Brain"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0770","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2006.02.011","article-title":"Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice","volume":"23","author":"Guidetti","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0775","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/hmg\/ddp527","article-title":"Expression analysis of novel striatal-enriched genes in Huntington disease","volume":"19","author":"Mazarei","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0780","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1471-4159.2005.03070.x","article-title":"Tryptophan metabolism and oxidative stress in patients with Huntington's disease","volume":"93","author":"Stoy","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0785","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1471-4159.2009.06442.x","article-title":"Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington's disease","volume":"112","author":"Forrest","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0790","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/j.1471-4159.2010.06675.x","article-title":"Dysfunctional kynurenine pathway metabolism in the R6\/2 mouse model of Huntington's disease","volume":"113","author":"Sathyasaikumar","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0795","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"Bjorkqvist","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0800","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/WNR.0b013e32832e34ee","article-title":"Distinct neuroinflammatory profile in post-mortem human Huntington's disease","volume":"20","author":"Silvestroni","year":"2009","journal-title":"Neuroreport"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0805","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington's disease gene carriers","volume":"130","author":"Tai","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0810","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2478\/v10039-010-0023-6","article-title":"Kynurenine and its metabolites in Alzheimer's disease patients","volume":"55","author":"Gulaj","year":"2010","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0815","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1179\/174329210X12650506623645","article-title":"Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease","volume":"15","author":"Bonda","year":"2010","journal-title":"Redox Rep"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0820","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00406-012-0384-x","article-title":"Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer's disease patients from controls","volume":"263","author":"Schwarz","year":"2013","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0825","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2990.2005.00655.x","article-title":"Indoleamine 2,3-dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus","volume":"31","author":"Guillemin","year":"2005","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0830","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1097\/00001756-200312190-00005","article-title":"A beta 1\u201342 induces production of quinolinic acid by human macrophages and microglia","volume":"14","author":"Guillemin","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0835","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1471-4159.2009.06175.x","article-title":"Proinflammatory cytokine interferon-gamma increases induction of indoleamine 2,3-dioxygenase in monocytic cells primed with amyloid beta peptide 1\u201342: implications for the pathogenesis of Alzheimer's disease","volume":"110","author":"Yamada","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0840","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/glia.1072","article-title":"Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro","volume":"35","author":"Lue","year":"2001","journal-title":"Glia"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0845","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ics.2007.07.026","article-title":"Up-regulation of the brain indoleamine 2,3-dioxygenase activity in a mouse model of Alzheimer's disease by systemic endotoxin challenge","volume":"1304","author":"Akimoto","year":"2007","journal-title":"Int Cong Ser"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0850","doi-asserted-by":"crossref","first-page":"e6344","DOI":"10.1371\/journal.pone.0006344","article-title":"The excitotoxin quinolinic acid induces tau phosphorylation in human neurons","volume":"4","author":"Rahman","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0855","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s007020200014","article-title":"Increased neopterin production and tryptophan degradation in advanced Parkinson's disease","volume":"109","author":"Widner","year":"2002","journal-title":"J Neural Transm"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0860","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1212\/WNL.42.9.1702","article-title":"Kynurenine pathway abnormalities in Parkinson's disease","volume":"42","author":"Ogawa","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0865","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ng1542","article-title":"A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease","volume":"37","author":"Giorgini","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0870","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cub.2011.04.028","article-title":"The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease","volume":"21","author":"Campesan","year":"2011","journal-title":"Curr Biol"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0875","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","article-title":"Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration","volume":"145","author":"Zwilling","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0880","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00109-013-1046-9","article-title":"The causative role and therapeutic potential of the kynurenine pathway in neurodegenerative disease","volume":"91","author":"Amaral","year":"2013","journal-title":"J Mol Med (Berl.)"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0885","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1021\/jm970467t","article-title":"Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase","volume":"40","author":"Rover","year":"1997","journal-title":"J Med Chem"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0890","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/mds.20596","article-title":"Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys","volume":"20","author":"Samadi","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0895","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1124\/dmd.112.046532","article-title":"Metabolism and pharmacokinetics of JM6 in mice: JM6 is not a prodrug for Ro-61-8048","volume":"40","author":"Beconi","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0900","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/mds.26007","article-title":"Targets for future clinical trials in Huntington's disease: what's in the pipeline?","volume":"29","author":"Wild","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0905","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1021\/jm501350y","article-title":"Development of a series of aryl pyrimidine kynurenine monooxygenase inhibitors as potential therapeutic agents for the treatment of Huntington's disease","volume":"58","author":"Toledo-Sherman","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0910","doi-asserted-by":"crossref","first-page":"36554","DOI":"10.1074\/jbc.M113.503813","article-title":"Targeted deletion of kynurenine 3-monooxygenase in mice: a new tool for studying kynurenine pathway metabolism in periphery and brain","volume":"288","author":"Giorgini","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0915","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature12039","article-title":"Structural basis of kynurenine 3-monooxygenase inhibition","volume":"496","author":"Amaral","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0920","doi-asserted-by":"crossref","first-page":"14912","DOI":"10.1073\/pnas.1203083109","article-title":"Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation","volume":"109","author":"van der Goot","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0925","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3233\/JAD-2010-100684","article-title":"Oren-gedoku-to and its constituents with therapeutic potential in Alzheimer's disease inhibit indoleamine 2,3-dioxygenase activity in vitro","volume":"22","author":"Yu","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.semcdb.2015.03.002_bib0930","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/JAD-140414","article-title":"The IDO inhibitor coptisine ameliorates cognitive impairment in a mouse model of Alzheimer's disease","volume":"43","author":"Yu","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.semcdb.2015.03.002_bib1930","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.expneurol.2013.08.007","article-title":"The absence of indoleamine 2,3-dioxygenase expression protects against NMDA receptor-mediated excitotoxicity in mouse brain","volume":"249","author":"Mazarei","year":"2013","journal-title":"Exp Neurol"}],"container-title":["Seminars in Cell & Developmental Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952115000452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952115000452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T20:04:30Z","timestamp":1717790670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1084952115000452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":94,"alternative-id":["S1084952115000452"],"URL":"https:\/\/doi.org\/10.1016\/j.semcdb.2015.03.002","relation":{},"ISSN":["1084-9521"],"issn-type":[{"value":"1084-9521","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The kynurenine pathway and neurodegenerative disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cell & Developmental Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcdb.2015.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}